AZ St.-Elisabeth Herentals vzw

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Rheumatoid arthritis2 trials
• Atrial fibrillation1 trial
• Coronary artery disease1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial
• Heart failure1 trial
• Multiple myeloma1 trial
• Obesity1 trial

Phase

• Phase 33 trials
• Phase 43 trials
• Phase 21 trial

Status

• Recruiting5 trials
• Completed1 trial
• Withdrawn1 trial

Lead sponsor

• Regeneron Pharmaceuticals3 trials
• Universitaire Ziekenhuizen KU Leuven2 trials
• Amgen Inc.1 trial
• UZ Leuven1 trial

Running trials

• Recruiting

  Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation

  NCT07405671· Phase 4· Universitaire Ziekenhuizen KU Leuven· Source

• Recruiting

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)

  2024-516654-22-00· Phase 3· Amgen Inc.· Source

• Recruiting

  A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

  NCT06140524· Phase 2· Regeneron Pharmaceuticals· Source

• Recruiting

  Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis

  NCT06003283· Phase 4· Universitaire Ziekenhuizen KU Leuven· Source

• Recruiting

  A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  NCT06091865· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting
• Coronary artery disease1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Heart failure1 recruiting
• Multiple myeloma1 recruiting
• Obesity1 recruiting
• Rheumatoid arthritis1 recruiting

Closed trials

• Recruiting

  A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  NCT06091254· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Completed

  RCT part: COBRA-Slim with or without fast access to TNF blockade for remission induction in early RA. LTE part: Long Term observational follow-up on patients started in CareRA2020 RCT (COBRA Slim with or without fast access to TNF blockade for remission induction in RA).

  NCT03649061· Phase 4· UZ Leuven· Source